ASCO 2021 - Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Watch Now ASCO 2021 - Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Ki67 – is it ready yet?

Watch Now Ki67 – is it ready yet?

ESMO BREAST 2021 - Breast Cancer Index and prediction of extended endocrine therapy / late relapse

Watch Now ESMO BREAST 2021 - Breast Cancer Index and prediction of extended endocrine therapy / late relapse

ESMO BREAST 2021 - HER2-low breast cancer - what is it anyway?

Watch Now ESMO BREAST 2021 - HER2-low breast cancer - what is it anyway?

Q&A with Dr. Melanie Spears on the Characterisation of immune “hot” ER+ breast cancer

Watch Now Q&A with Dr. Melanie Spears on the Characterisation of immune “hot” ER+ breast cancer